outcomes research

Research in Review

Neoadjuvant Chemotherapy May Induce Breast Cancer Metastasis

07/10/2017

JCP Editors

A neoadjuvant chemotherapy combination used to treat breast cancer increases the risk of disease metastasis, according to recent research published in Science Translational Medicine (published online July 5, 2017;...

A...

07/10/2017

Journal of Clinical Pathways

Research in Review

CAR-T Therapy Response Independent of Disease Factors in NHL

07/10/2017

JCP Editors

A recent clinical trial of a chimeric antigen receptor (CAR) T-cell therapy showed a significantly high response rate in treatment-resistant and relapsed aggressive non-Hodgkin lymphoma (NHL) independent of disease...

A...

07/10/2017

Journal of Clinical Pathways

Research in Review

Does Intensified Therapy Improve Prognosis in DLBCL?

07/03/2017

JCP Editors

Recent research compared the effects of standard chemotherapy dosage with intensified chemotherapy for patients with high-risk diffuse large B-cell lymphoma (DLBCL), published in The Lancet Oncology (published online...

Recent...

07/03/2017

Journal of Clinical Pathways

Research in Review

Common Second-Line Treatment for Liver Cancer Deemed Not Cost-Effective

07/03/2017

JCP Editors

A conventional second-line treatment for hepatocellular carcinoma offers only a marginal increase in quality-adjusted life-years (QALYs) at a significantly high cost, according to an analysis published in Cancer...

A...

07/03/2017

Journal of Clinical Pathways

Research in Review

Decreasing TKI Dosage Provides Better Outcomes in CML, Lowers Costs

06/29/2017

JCP Editors

Patients with chronic myeloid leukemia (CML) who receive half the standard dose of tyrosine kinase inhibitor (TKI) therapy are likely to eliminate most adverse events, drastically reduce costs, and improve...

...

06/29/2017

Journal of Clinical Pathways

Research in Review

Adjuvant Ovarian Function Suppression Improves Breast Cancer Treatment Outcomes

06/29/2017

JCP Editors

In younger women with hormone receptor (HR)-positive breast cancer, ovarian function suppression (OFS) after surgery drives large improvements in breast cancer-free interval when combined with drug therapy, according...

In...

06/29/2017

Journal of Clinical Pathways

Research in Review

Does Delayed Lymph Node Biopsy Affect Survival Rates in Melanoma?

06/29/2017

JCP Editors

Recent research compared survival outcomes of patients newly diagnosed with melanoma who received a sentinel lymph node biopsy within 30 days and those who received biopsy after 30 days, published in the Journal of...

Recent...

06/29/2017

Journal of Clinical Pathways

Research in Review

High Rates of Chronic Opioid Use Persist in Older Patients With RA

06/29/2017

JCP Editors

Despite a small decline in chronic opioid use after 2010, recent research suggests that 40% of older patients with rheumatoid arthritis (RA) still take opioids regularly as of 2014, published in Arthritis &...

...

06/29/2017

Journal of Clinical Pathways

Research in Review

Prostate Cancer Scanning Helps Detect Further Disease, Improve Care

06/28/2017

JCP Editors

Positron emission tomography (PET) and computed tomography (CT) scans specific to prostate cancer can detect further disease and improve clinical management, according to recent research. Ga68-Prostate Specific...

...

06/28/2017

Journal of Clinical Pathways

Research in Review

New Prognostic Model Accurately Predicts Survival in Lung Cancer With Brain Metastases

06/28/2017

JCP Editors

A new prognostic model for lung cancer with brain metastases uses histology, mutations, number of metastases, performance status, and age to accurately predict survival outcomes in patients, according to research...

A new...

06/28/2017

Journal of Clinical Pathways